149 related articles for article (PubMed ID: 9433369)
1. Peripheral H1-blockade effect of fexofenadine.
Simons FE; Simons KJ
Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
[TBL] [Abstract][Full Text] [Related]
2. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
4. Similar rapid onset of action and magnitude of effect of fexofenadine and cetirizine as assessed by inhibition of histamine-induced wheal-and-flare reaction.
Purohit A; N'Gom AS; Deslandes B; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):562-7. PubMed ID: 15609766
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
Carey W; Warrington S; Boyce M; Luria X
Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
[TBL] [Abstract][Full Text] [Related]
8. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance.
Takahashi H; Ishida-Yamamoto A; Iizuka H
Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340
[TBL] [Abstract][Full Text] [Related]
9. Skin concentrations of H1-receptor antagonists.
Simons FE; Silver NA; Gu X; Simons KJ
J Allergy Clin Immunol; 2001 Mar; 107(3):526-30. PubMed ID: 11240955
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of fexofenadine versus desloratadine in suppressing histamine-induced wheal and flare.
Meltzer EO; Gillman SA
Allergy Asthma Proc; 2007; 28(1):67-73. PubMed ID: 17390761
[TBL] [Abstract][Full Text] [Related]
11. Effects of fexofenadine on the early response to nasal allergen challenge.
Allocco FT; Votypka V; deTineo M; Naclerio RM; Baroody FM
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):578-84. PubMed ID: 12487223
[TBL] [Abstract][Full Text] [Related]
12. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
13. The effects of butterbur on the histamine and allergen cutaneous response.
Jackson CM; Lee DK; Lipworth BJ
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):250-4. PubMed ID: 14989395
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ebastine, cetirizine, and loratadine in histamine cutaneous challenges.
Gispert J; Antonijoan R; Barbanoj M; Gich I; Garcia E; Esbrí R; Luria X
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):259-64. PubMed ID: 12269645
[TBL] [Abstract][Full Text] [Related]
15. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.
Jones DH; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2008 May; 100(5):452-6. PubMed ID: 18517077
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system effects of H1-receptor antagonists in the elderly.
Simons FE; Fraser TG; Maher J; Pillay N; Simons KJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):157-60. PubMed ID: 10071518
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects.
Grant JA; Danielson L; Rihoux JP; DeVos C
Allergy; 1999 Jul; 54(7):700-7. PubMed ID: 10442525
[TBL] [Abstract][Full Text] [Related]
20. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial].
Kłos K; Kruszewski J; Kruszewski R; Sułek K
Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
